3,6-Di-tert-butylacridin-9(10H)-one, 98%, 250mg

4-(3-Fluorophenyl)-piperidine hydrochloride, 97.0%, 5g

8-Bromopyrido[4,3-d]pyrimidin-4(3H)-one, 97%, 1g

2-(4-Fluorophenyl)thiazole-4-carbaldehyde, 95.0%, 2.5g

4-(5-((3-Benzyl-4-oxo-2-thioxothiazolidin-5-ylidene)methyl)furan-2-yl)benzoic acid, 98%, 250mg

2-Bromo-4-(3-(pyridin-2-yl)-1H-pyrazol-4-yl)pyridine, 95.0%, 5g

tert-Butyl (3-(cyanomethyl)bicyclo[1.1.1]pentan-1-yl)carbamate, 98%, 5g

5-Bromo-N-isobutylpicolinamide, 98%, 1g

(S)-4-methylthiazolidine-2-thione, 5g

Tripropylene glycol monomethyl ether, min 97%, for synthesis, 1L, plastic packaging.

4-(propan-2-yl)-2-(pyrrolidin-2-yl)-1,3-oxazole dihydrochloride, 95.0%, 500mg

N-Boc-2-Amino-5-methylpyrazine, 95.0%, 250mg

Trimethyl (E)-prop-1-ene-1,2,3-tricarboxylate, 98%, 5g